No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven ...

President Trump has vowed to impose tariffs on China, Mexico, and Canada. They could make common medicines less affordable.

Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S.

However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Pfizer Inc. ( NYSE:PFE ) will increase its dividend from last year's comparable payment on the 7th of March to ...